<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Myocardial Infarction]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/diseases-conditions/myocardial-infarction</link>
    <description><![CDATA[Myocardial Infarction]]></description>
    <pubDate>Tue, 05 May 2026 21:31:19 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Myocardial Infarction - Pipeline Review, H1 2020]]></title>
      <link>https://www.leadingmarketresearch.com/myocardial-infarction-pipeline-review-h1-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H1 2020, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape.<br><br>Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain, toothache, headache, shortness of breath, nausea, vomiting, and/or general epigastric discomfort, sweating, heartburn and/or indigestion, arm pain, upper back pain and general malaise (vague feeling of illness). <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Myocardial Infarction - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Myocardial Infarction (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descrip...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-214889"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 07 May 2020 13:39:47 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Myocarditis - Pipeline Review, H1 2019]]></title>
      <link>https://www.leadingmarketresearch.com/myocarditis-pipeline-review-h1-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Pipeline Review, H1 2019, provides an overview of the Myocarditis (Cardiovascular) pipeline landscape.<br><br>Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain, rapid or abnormal heartbeat, shortness of breath, at rest or during physical activity, fluid retention with swelling of legs, ankles and feet and fatigue. Treatment includes antibiotics, anti-inflammatory medicines to reduce swelling and diuretics to remove excess water from the body. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Myocarditis - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Myocarditis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (R...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208031"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 26 Mar 2019 12:29:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Myocardial Infarction - Pipeline Review, H1 2019]]></title>
      <link>https://www.leadingmarketresearch.com/myocardial-infarction-pipeline-review-h1-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H1 2019, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape.<br><br>Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain, toothache, headache, shortness of breath, nausea, vomiting, and/or general epigastric discomfort, sweating, heartburn and/or indigestion, arm pain, upper back pain and general malaise (vague feeling of illness). <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Myocardial Infarction - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Myocardial Infarction (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descrip...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208034"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 26 Mar 2019 12:29:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Myocardial Infarction - Pipeline Review, H1 2017]]></title>
      <link>https://www.leadingmarketresearch.com/myocardial-infarction-pipeline-review-h1-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction – Pipeline Review, H1 2017, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape.<br><br>Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain, toothache, headache, shortness of breath, nausea, vomiting, and/or general epigastric discomfort, sweating, heartburn and/or indigestion, arm pain, upper back pain and general malaise (vague feeling of illness).<br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Myocardial Infarction – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Myocardial Infarction (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the desc...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-193169"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 05 Apr 2017 15:52:18 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Myocardial Infarction  - Market Insights, Epidemiology and Market Forecast-2023]]></title>
      <link>https://www.leadingmarketresearch.com/myocardial-infarction-market-insights-epidemiology-and-market-forecast</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Myocardial Infarction for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Myocardial Infarction forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Myocardial Infarction till 2023. 

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Myocardial Infarction market. 
• Identifying patient populations in the global “Myocardial Infarction market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Myocardial Infarction therapeutics in each of the markets covered.
• To understand the future mark...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-183826"><span class="price">$4,950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 24 Aug 2016 13:19:26 +0000</pubDate>
    </item>
  </channel>
</rss>
